AASLD

AASLD Founded in 1950, AASLD is the leading organization of scientists and health care professionals committed to preventing and curing liver disease.

12/11/2025

Experts, patients, and innovators all in one place! .nutrition shared her Day 1 recap from , highlighting the sessions she attended and the ones she’s planning to dive into next.

🎥 .nutrition

12/10/2025

Scrolling through your pics like… 😍

AASLD is proud to announce the next Co-Editors-in-Chief of HEPATOLOGY: Dr. Naga Chalasani (Indiana University School of ...
12/09/2025

AASLD is proud to announce the next Co-Editors-in-Chief of HEPATOLOGY: Dr. Naga Chalasani (Indiana University School of Medicine) and Dr. Laura E. Nagy (Cleveland Clinic).

Beginning their five-year term in January 2027, Drs. Chalasani and Nagy bring decades of leadership, groundbreaking research, and deep commitment to advancing hepatology.

Join us in congratulating them and thanking Dr. Gregory Gores for his exceptional leadership and service as outgoing Editor-in-Chief.

Read more here: https://www.aasld.org/aasld-announces-new-co-editors-chief-hepatology

Learn more about HEPATOLOGY at https://journals.lww.com/hep/pages/default.aspx and follow the journal on X .

The Call for Abstracts for AASLD’s 2026 Emerging Topic Conference is now open! Present your work among peers shaping the...
12/09/2025

The Call for Abstracts for AASLD’s 2026 Emerging Topic Conference is now open!

Present your work among peers shaping the future of diagnostics and treatment strategies. We’re encouraging submissions from trainees, early-career investigators, and industry researchers working on:

✅Alcohol-related Liver Disease

✅MASLD

✅PBC

Submit by Jan. 12, 2026: https://bit.ly/3MfWFh9

‼️ACTION NEEDED: Protect the hepatitis B birth dose!Last week, the ACIP voted to end the universal hepatitis B birth dos...
12/08/2025

‼️ACTION NEEDED: Protect the hepatitis B birth dose!

Last week, the ACIP voted to end the universal hepatitis B birth dose and delay vaccination for many newborns until two months of age. This goes against decades of scientific evidence and leaves infants vulnerable to chronic hepatitis B infection and liver cancer.

There is still time to stop this.

Congress must urge HHS and CDC to reject this harmful change and keep the universal birth dose in the immunization schedule.

Take action now! Contact your representatives and tell them to protect newborns: https://www.aasld.org/aasld-policy-action-center #/

‼️AASLD and six leading medical societies are sounding the alarm after ACIP voted to end the universal hepatitis B birth...
12/05/2025

‼️AASLD and six leading medical societies are sounding the alarm after ACIP voted to end the universal hepatitis B birth dose recommendation.

The hepatitis B vaccine given at birth protects infants from lifelong liver disease and liver cancer. Ending this recommendation puts newborns at risk, widens existing screening gaps, and threatens decades of public health progress.

We’re urging the CDC to reverse this decision and reaffirm the universal birth dose as a critical tool to keep every infant safe.

👉 Read the full statement here: https://www.aasld.org/aasld-partner-organizations-sound-alarm-reverse-acips-hepatitis-b-birth-dose-rollback-now

Your work deserves the global stage! AASLD is pleased to share that our partners at the International Liver Transplantat...
12/04/2025

Your work deserves the global stage!

AASLD is pleased to share that our partners at the International Liver Transplantation Society are now accepting abstracts for the 2025 International Congress of the ILTS.

This global meeting brings together experts across the field of liver transplantation to advance research, clinical practice, and innovation.

🔗 Submit your abstract and be part of the scientific program: https://ilts-congress.org/abstracts/?fbclid=IwZXh0bgNhZW0CMTAAYnJpZBEwM2tjbmtRTlc0THYzSnQxdHNydGMGYXBwX2lkEDIyMjAzOTE3ODgyMDA4OTIAAR5yq2Odc1XAnvvS8sU77fCsDKbdKJmwBsRAeonCFT6SMDS0lMkeYvgAnrycyA_aem_vBiwfKo3bijOfbf1sLi9Aw&brid=KbaQcPIPVptwhqXqjo052A

📣 Paris PSVD Meeting, Session 1 on Dec. 4Join us tomorrow as we deep dive into pathophysiologyand conditions associated ...
12/03/2025

📣 Paris PSVD Meeting, Session 1 on Dec. 4

Join us tomorrow as we deep dive into pathophysiology
and conditions associated with Porto-Sinusoidal Vascular Disease.

Topics include:
✅ Prognosis and treatment impact
✅ Genetics and PSVD
✅ Pathophysiology: is PSVD an immune, a vascular, or
coagulation disorder?
✅ Preclinical models of PSVD

Add to your schedule: https://www.valdig.eu/paris-psvd-meeting/

📣 Join us in two weeks!Don’t miss “Resmetirom and Semaglutide for MASH in 2025: Updated Recommendations from AASLD Guida...
12/02/2025

📣 Join us in two weeks!
Don’t miss “Resmetirom and Semaglutide for MASH in 2025: Updated Recommendations from AASLD Guidance” — a live webinar discussing the latest updates in MASLD/MASH management, including current and emerging therapies.

📅 Tuesday, December 16, 2025
🕛 12:00 noon EST
🎙 Moderator & Panelists: Robert Fontana, MD, FAASLD, Alina Allen, MD, Jessica Bartholomew, NP, Yaron Rotman, MD, MSc, FAASLD, Meena Bensal, MD, FAASLD
💡 Earn AMA PRA Category 1 Credit™

Register today: https://www.aasld.org/resmetirom-and-semaglutide-mash-2025-updated-recommendations-aasld-guidance

In conjunction with ALEH, join AASLD’s Dr. Juan Pablo Arab and leading experts as they discuss the latest advancements i...
12/01/2025

In conjunction with ALEH, join AASLD’s Dr. Juan Pablo Arab and leading experts as they discuss the latest advancements in ALD and MetALD. Don’t miss this exciting collaboration — screening strategies, treatment approaches, current controversies, and updates on early liver transplantation will be reviewed. https://bit.ly/49E22Ax

Address

1001 N Fairfax Street, 4th Floor
Alexandria, VA
22314

Opening Hours

Monday 9am - 5pm
Tuesday 9am - 5pm
Wednesday 9am - 5pm
Thursday 9am - 5pm
Friday 9am - 5pm

Telephone

+17032999766

Website

Alerts

Be the first to know and let us send you an email when AASLD posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to AASLD:

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category